Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 9 | 2025 | 3020 | 1.380 |
Why?
|
| Health Expenditures | 3 | 2020 | 91 | 1.270 |
Why?
|
| Bariatric Surgery | 4 | 2020 | 201 | 1.260 |
Why?
|
| Medicare | 4 | 2022 | 429 | 1.120 |
Why?
|
| Surgeons | 4 | 2020 | 252 | 1.110 |
Why?
|
| Mastectomy, Segmental | 2 | 2024 | 101 | 0.970 |
Why?
|
| Neoadjuvant Therapy | 3 | 2025 | 388 | 0.900 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2025 | 176 | 0.890 |
Why?
|
| Academic Medical Centers | 3 | 2020 | 388 | 0.740 |
Why?
|
| Mentoring | 2 | 2018 | 33 | 0.720 |
Why?
|
| Health Care Costs | 2 | 2020 | 237 | 0.700 |
Why?
|
| Leadership | 2 | 2019 | 144 | 0.680 |
Why?
|
| Surgery Department, Hospital | 1 | 2020 | 45 | 0.670 |
Why?
|
| Personnel Selection | 1 | 2020 | 62 | 0.660 |
Why?
|
| Healthcare Disparities | 3 | 2025 | 429 | 0.660 |
Why?
|
| Mastectomy | 5 | 2025 | 252 | 0.610 |
Why?
|
| Gastroplasty | 1 | 2018 | 26 | 0.580 |
Why?
|
| Elective Surgical Procedures | 1 | 2019 | 132 | 0.580 |
Why?
|
| Personality | 1 | 2018 | 138 | 0.550 |
Why?
|
| Gastric Bypass | 1 | 2018 | 114 | 0.530 |
Why?
|
| Weight Loss | 1 | 2018 | 235 | 0.520 |
Why?
|
| Obesity, Morbid | 1 | 2018 | 242 | 0.480 |
Why?
|
| Decision Support Techniques | 1 | 2014 | 170 | 0.400 |
Why?
|
| Receptor, ErbB-2 | 2 | 2024 | 253 | 0.400 |
Why?
|
| Hospitalization | 1 | 2017 | 899 | 0.390 |
Why?
|
| Surgical Procedures, Operative | 1 | 2014 | 208 | 0.380 |
Why?
|
| Retrospective Studies | 9 | 2025 | 9330 | 0.350 |
Why?
|
| Female | 17 | 2025 | 46894 | 0.350 |
Why?
|
| Humans | 25 | 2025 | 90640 | 0.340 |
Why?
|
| Practice Guidelines as Topic | 2 | 2020 | 1056 | 0.300 |
Why?
|
| Physicians, Women | 2 | 2019 | 58 | 0.300 |
Why?
|
| Aged | 9 | 2025 | 19424 | 0.300 |
Why?
|
| United States | 9 | 2025 | 7142 | 0.290 |
Why?
|
| General Surgery | 2 | 2019 | 244 | 0.270 |
Why?
|
| Hospitals | 2 | 2020 | 309 | 0.260 |
Why?
|
| Neoplasm Staging | 3 | 2024 | 2019 | 0.230 |
Why?
|
| Upper Extremity | 1 | 2025 | 57 | 0.230 |
Why?
|
| Postoperative Complications | 3 | 2025 | 2342 | 0.220 |
Why?
|
| Cause of Death | 1 | 2024 | 270 | 0.220 |
Why?
|
| Receptors, Progesterone | 1 | 2024 | 176 | 0.220 |
Why?
|
| Social Determinants of Health | 1 | 2024 | 104 | 0.220 |
Why?
|
| Colectomy | 3 | 2022 | 175 | 0.220 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2025 | 203 | 0.210 |
Why?
|
| Mammaplasty | 1 | 2025 | 116 | 0.210 |
Why?
|
| Registries | 2 | 2024 | 812 | 0.200 |
Why?
|
| Receptors, Estrogen | 1 | 2024 | 395 | 0.200 |
Why?
|
| Neoplasms | 1 | 2017 | 3030 | 0.200 |
Why?
|
| Proportional Hazards Models | 1 | 2024 | 841 | 0.200 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2024 | 1362 | 0.200 |
Why?
|
| Program Development | 2 | 2019 | 128 | 0.190 |
Why?
|
| Organizational Policy | 2 | 2019 | 55 | 0.190 |
Why?
|
| Genes, BRCA2 | 1 | 2022 | 161 | 0.180 |
Why?
|
| Middle Aged | 7 | 2025 | 26347 | 0.180 |
Why?
|
| Aftercare | 1 | 2022 | 88 | 0.180 |
Why?
|
| Faculty, Medical | 2 | 2020 | 193 | 0.180 |
Why?
|
| Laparoscopy | 2 | 2018 | 782 | 0.180 |
Why?
|
| Health Status Disparities | 1 | 2023 | 192 | 0.180 |
Why?
|
| Job Application | 1 | 2020 | 13 | 0.170 |
Why?
|
| Women | 1 | 2020 | 25 | 0.170 |
Why?
|
| Travel | 1 | 2020 | 72 | 0.170 |
Why?
|
| Adult | 6 | 2025 | 26953 | 0.170 |
Why?
|
| Unnecessary Procedures | 1 | 2020 | 53 | 0.170 |
Why?
|
| Endoscopy, Digestive System | 1 | 2020 | 69 | 0.170 |
Why?
|
| Stakeholder Participation | 1 | 2019 | 22 | 0.160 |
Why?
|
| Internship and Residency | 2 | 2019 | 1068 | 0.160 |
Why?
|
| Immunotherapy | 1 | 2025 | 702 | 0.160 |
Why?
|
| Comorbidity | 2 | 2022 | 955 | 0.160 |
Why?
|
| Patient Discharge | 1 | 2022 | 328 | 0.160 |
Why?
|
| Treatment Outcome | 4 | 2020 | 8379 | 0.160 |
Why?
|
| Survival Rate | 1 | 2023 | 1895 | 0.160 |
Why?
|
| Role | 1 | 2018 | 11 | 0.150 |
Why?
|
| Lactation | 1 | 2018 | 54 | 0.150 |
Why?
|
| Peer Review, Health Care | 1 | 2018 | 6 | 0.150 |
Why?
|
| Radiology Department, Hospital | 1 | 2018 | 25 | 0.150 |
Why?
|
| Anastomotic Leak | 1 | 2020 | 104 | 0.150 |
Why?
|
| Formative Feedback | 1 | 2018 | 13 | 0.150 |
Why?
|
| Universities | 1 | 2019 | 147 | 0.150 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2021 | 604 | 0.150 |
Why?
|
| Breast Feeding | 1 | 2019 | 105 | 0.150 |
Why?
|
| Pulmonary Surgical Procedures | 1 | 2017 | 8 | 0.150 |
Why?
|
| Linear Models | 1 | 2019 | 427 | 0.150 |
Why?
|
| Health Promotion | 1 | 2019 | 164 | 0.140 |
Why?
|
| Peer Group | 1 | 2018 | 87 | 0.140 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 6816 | 0.140 |
Why?
|
| Referral and Consultation | 1 | 2020 | 349 | 0.140 |
Why?
|
| Stents | 1 | 2020 | 416 | 0.130 |
Why?
|
| Dyslipidemias | 1 | 2018 | 107 | 0.130 |
Why?
|
| Pancreatectomy | 1 | 2017 | 164 | 0.130 |
Why?
|
| Biomarkers, Tumor | 1 | 2024 | 1549 | 0.130 |
Why?
|
| Cohort Studies | 1 | 2023 | 2891 | 0.130 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 283 | 0.130 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2014 | 27 | 0.110 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 1088 | 0.110 |
Why?
|
| United Kingdom | 1 | 2014 | 167 | 0.110 |
Why?
|
| Decision Making | 2 | 2021 | 672 | 0.110 |
Why?
|
| Male | 4 | 2020 | 42967 | 0.100 |
Why?
|
| Hypertension | 1 | 2018 | 746 | 0.100 |
Why?
|
| Risk Assessment | 1 | 2019 | 2338 | 0.090 |
Why?
|
| Michigan | 2 | 2019 | 53 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 1199 | 0.080 |
Why?
|
| Qualitative Research | 2 | 2019 | 313 | 0.070 |
Why?
|
| Prognosis | 2 | 2024 | 3813 | 0.070 |
Why?
|
| Incidence | 2 | 2020 | 1594 | 0.060 |
Why?
|
| Follow-Up Studies | 2 | 2024 | 3698 | 0.060 |
Why?
|
| Surgical Flaps | 1 | 2025 | 254 | 0.050 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2023 | 478 | 0.050 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2021 | 77 | 0.050 |
Why?
|
| Axilla | 1 | 2021 | 104 | 0.050 |
Why?
|
| Episode of Care | 1 | 2020 | 7 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2023 | 1709 | 0.040 |
Why?
|
| Cost Savings | 1 | 2020 | 71 | 0.040 |
Why?
|
| Lymph Node Excision | 1 | 2021 | 222 | 0.040 |
Why?
|
| Canada | 1 | 2020 | 201 | 0.040 |
Why?
|
| Genomics | 1 | 2024 | 784 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2019 | 311 | 0.040 |
Why?
|
| Reoperation | 1 | 2020 | 609 | 0.030 |
Why?
|
| Video Recording | 1 | 2018 | 204 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 1738 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 2782 | 0.030 |
Why?
|
| Education, Medical, Graduate | 1 | 2018 | 406 | 0.030 |
Why?
|
| Obesity | 1 | 2020 | 979 | 0.030 |
Why?
|